# OnCo record paper-pathfinder-2-nat-med-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-pathfinder-2-nat-med-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-pathfinder-2-nat-med-2026" ;
  schema:name "Performance and safety of a multi-cancer early detection test: the PATHFINDER 2 study"@en ;
  schema:description "In 35,878 US adults aged 50 and over, the Galleri blood test was positive in a little over one in two hundred tested people who turned out to have cancer, six in ten positives were cancer, and it found about four in ten of the cancers diagnosed within a year."@en ;
  schema:url <https://onco.cc/key-papers/paper-pathfinder-2-nat-med-2026/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41591-026-04618-w>, <https://pubmed.ncbi.nlm.nih.gov/42773207/>, <https://clinicaltrials.gov/study/NCT05155605> ;
  schema:sameAs <https://doi.org/10.1038/s41591-026-04618-w> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Nabavizadeh N, McDonnell C, Kurbegov D, et al." ;
  onco:related <https://onco.cc/key-papers/paper-pathfinder-lancet-2023/> ;
  onco:sections <https://onco.cc/fronts/early-detection/> ;
  onco:technologies <https://onco.cc/technologies/mced/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/cfdna-methylation-testing/> ;
  onco:drugs <https://onco.cc/drugs/galleri/> ;
  onco:companies <https://onco.cc/companies/grail/> ;
  onco:terms <https://onco.cc/terms/ppv/>, <https://onco.cc/terms/screening/> ;
  onco:trials <https://onco.cc/trials/pathfinder-2/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-early-detection/> ;
  onco:journals <https://onco.cc/journals/nature-medicine/> .